1. Home
  2. MDXH vs MTC Comparison

MDXH vs MTC Comparison

Compare MDXH & MTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • MTC
  • Stock Information
  • Founded
  • MDXH 2003
  • MTC 2015
  • Country
  • MDXH Belgium
  • MTC Hong Kong
  • Employees
  • MDXH N/A
  • MTC N/A
  • Industry
  • MDXH
  • MTC Computer Software: Prepackaged Software
  • Sector
  • MDXH
  • MTC Technology
  • Exchange
  • MDXH Nasdaq
  • MTC Nasdaq
  • Market Cap
  • MDXH 93.1M
  • MTC 152.7M
  • IPO Year
  • MDXH 2021
  • MTC 2019
  • Fundamental
  • Price
  • MDXH $2.00
  • MTC $1.46
  • Analyst Decision
  • MDXH Strong Buy
  • MTC
  • Analyst Count
  • MDXH 2
  • MTC 0
  • Target Price
  • MDXH $7.00
  • MTC N/A
  • AVG Volume (30 Days)
  • MDXH 136.8K
  • MTC 304.5K
  • Earning Date
  • MDXH 02-26-2025
  • MTC 01-21-2025
  • Dividend Yield
  • MDXH N/A
  • MTC N/A
  • EPS Growth
  • MDXH N/A
  • MTC N/A
  • EPS
  • MDXH N/A
  • MTC 1.16
  • Revenue
  • MDXH $84,708,000.00
  • MTC N/A
  • Revenue This Year
  • MDXH $27.57
  • MTC N/A
  • Revenue Next Year
  • MDXH $20.09
  • MTC N/A
  • P/E Ratio
  • MDXH N/A
  • MTC $1.44
  • Revenue Growth
  • MDXH 33.01
  • MTC N/A
  • 52 Week Low
  • MDXH $1.55
  • MTC $0.18
  • 52 Week High
  • MDXH $4.44
  • MTC $12.90
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 40.19
  • MTC 59.75
  • Support Level
  • MDXH $1.96
  • MTC $1.32
  • Resistance Level
  • MDXH $2.25
  • MTC $1.90
  • Average True Range (ATR)
  • MDXH 0.18
  • MTC 0.20
  • MACD
  • MDXH -0.05
  • MTC -0.04
  • Stochastic Oscillator
  • MDXH 5.71
  • MTC 31.25

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About MTC MMTec Inc.

MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, MMBD Advisory and HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.

Share on Social Networks: